Takeda Pharmaceutical Company Limited American Depositary Shares (each r (TAK) Covered Calls
You can sell covered calls on Takeda Pharmaceutical Company Limited American Depositary Shares (each r to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for TAK (prices last updated Fri 4:16 PM ET):
Takeda Pharmaceutical Company Limited American Depositary Shares (each r (TAK) Stock Quote | ||||||
---|---|---|---|---|---|---|
Last | Change | Bid | Ask | Volume | P/E | Market Cap |
13.10 | +0.09 | 13.02 | 13.50 | 1.8M | - | 0.0 |
Covered Calls For Takeda Pharmaceutical Company Limited American Depositary Shares (each r (TAK) | ||||||
---|---|---|---|---|---|---|
Expiration | Strike | Call Bid | Net Debit | Return If Flat |
Annualized Return If Flat |
|
Jan 17 | 12.5 | 0.45 | 13.05 | -4.2% | -52.9% | |
Feb 21 | 12.5 | 0.00 | 13.50 | -7.4% | -42.2% | |
Subscribers get access to the full covered call chain, and more features. |
Want to make money with covered calls? Sign Up For A Free Trial
Extended Business Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacturing, and marketing of pharmaceutical products, over-the-counter medicines and quasi-drug consumer products, and other healthcare products. It offers pharmaceutical products in the areas of gastroenterology; oncology; neuroscience; and rare diseases, such as rare metabolic and hematology, and heredity angioedema, as well as plasma-derived therapies and vaccines. The company provides its products under the ENTYVIO, GATTEX/REVESTIVE, ALOFISEL, NATPARA, ADYNOVATE/ADYNOVI, TAKHZYRO, ELAPRASE, VPRIV, GAMMAGARD LIQUID/KIOVIG, HYQVIA, CUVITRU, ALBUMIN/FLEXBUMIN, NINLARO, and ALUNBRIG brands. It operates in Japan, the United States, Europe and Canada, Russia/CIS, Latin America, rest of Asia, the Middle East, Oceania, and Africa. The company has licensing agreements with TESARO, Inc., Denali Therapeutics, and Wave Life Sciences Ltd; collaboration agreements with Rani Therapeutics LLC, Novimmune S.A., AB Biosciences Inc., Sosei Group Corporation, and LogicBio Therapeutics, Inc.; strategic collaboration with Prometheus Biosciences, Inc; a license and research agreement with The University of Texas MD Anderson Cancer Center; a research collaboration agreements with Enzyre BV and Cerevance; a collaboration agreement with Artisan Bio, Inc.; and a multi-target rare disease collaboration with Evox Therapeutics Ltd., as well as licensing agreement with ProThera Biologics Inc. It also has a corporate strategic research alliance with Egle Therapeutics SAS; a strategic partnership with Neurocrine Biosciences, Inc.; Carmine Therapeutics and HemoShear Therapeutics, LLC. Takeda Pharmaceutical Company Limited was founded in 1781 and is headquartered in Tokyo, Japan.
Top 10 Open Interest For Jan 17 Expiration | Top 5 High Yield | |||||
---|---|---|---|---|---|---|
1. | NVDA covered calls | 6. | INTC covered calls | 1. | RGTI covered calls | |
2. | SLV covered calls | 7. | SPY covered calls | 2. | NMRA covered calls | |
3. | AAPL covered calls | 8. | TSLA covered calls | 3. | HUMA covered calls | |
4. | EEM covered calls | 9. | IWM covered calls | 4. | DLO covered calls | |
5. | XLF covered calls | 10. | TLT covered calls | 5. | MARA covered calls |
Want more examples? TAIL Covered Calls | TAL Covered Calls